Jie Zhang1, Alan R Light1, Charles L Hoppel2, Caitlin Campbell3, Carol J Chandler3, Dustin J Burnett3, Elaine C Souza3, Gretchen A Casazza4, Ronald W Hughen1, Nancy L Keim3,5, John W Newman3,5, Gary R Hunter6,7, Jose R Fernandez6, W Timothy Garvey6, Mary-Ellen Harper8, Oliver Fiehn9,10, Sean H Adams11,12. 1. Anesthesiology Department, University of Utah School of Medicine, Salt Lake City, UT, USA. 2. Pharmacology Department, Case Western Reserve University, Cleveland, OH, USA. 3. United States Department of Agriculture-Agricultural Research Service Western Human Nutrition Research Center, Davis, CA, USA. 4. Sports Medicine Program, School of Medicine, University of California, Davis, CA, USA. 5. Department of Nutrition, University of California, Davis, CA, USA. 6. Department of Nutrition Sciences, University of Alabama, Birmingham, AL, USA. 7. Human Studies Department, University of Alabama, Birmingham, AL, USA. 8. Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, ON, Canada. 9. Genome Center and West Coast Metabolomics Center, University of California, Davis, CA, USA. 10. Biochemistry Department, King Abdulaziz University, Jeddah, Saudi-Arabia. 11. Arkansas Children's Nutrition Center, Little Rock, AR, USA. 12. Department of Pediatrics, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
Abstract
NEW FINDINGS: What is the central question of this study? Does improved metabolic health and insulin sensitivity following a weight-loss and fitness intervention in sedentary, obese women alter exercise-associated fuel metabolism and incomplete mitochondrial fatty acid oxidation (FAO), as tracked by blood acylcarnitine patterns? What is the main finding and its importance? Despite improved fitness and blood sugar control, indices of incomplete mitochondrial FAO increased in a similar manner in response to a fixed load acute exercise bout; this indicates that intramitochondrial muscle FAO is inherently inefficient and is tethered directly to ATP turnover. With insulin resistance or type 2 diabetes mellitus, mismatches between mitochondrial fatty acid fuel delivery and oxidative phosphorylation/tricarboxylic acid cycle activity may contribute to inordinate accumulation of short- or medium-chain acylcarnitine fatty acid derivatives [markers of incomplete long-chain fatty acid oxidation (FAO)]. We reasoned that incomplete FAO in muscle would be ameliorated concurrent with improved insulin sensitivity and fitness following a ∼14 week training and weight-loss intervention in obese, sedentary, insulin-resistant women. Contrary to this hypothesis, overnight-fasted and exercise-induced plasma C4-C14 acylcarnitines did not differ between pre- and postintervention phases. These metabolites all increased robustly with exercise (∼45% of pre-intervention peak oxygen consumption) and decreased during a 20 min cool-down. This supports the idea that, regardless of insulin sensitivity and fitness, intramitochondrial muscle β-oxidation and attendant incomplete FAO are closely tethered to absolute ATP turnover rate. Acute exercise also led to branched-chain amino acid acylcarnitine derivative patterns suggestive of rapid and transient diminution of branched-chain amino acid flux through the mitochondrial branched-chain ketoacid dehydrogenase complex. We confirmed our prior novel observation that a weight-loss/fitness intervention alters plasma xenometabolites [i.e. cis-3,4-methylene-heptanoylcarnitine and γ-butyrobetaine (a co-metabolite possibly derived in part from gut bacteria)], suggesting that host metabolic health regulated gut microbe metabolism. Finally, we considered whether acylcarnitine metabolites signal to muscle-innervating afferents; palmitoylcarnitine at concentrations as low as 1-10 μm activated a subset (∼2.5-5%) of these neurons ex vivo. This supports the hypothesis that in addition to tracking exercise-associated shifts in fuel metabolism, muscle acylcarnitines act as signals of exertion to short-loop somatosensory-motor circuits or to the brain.
NEW FINDINGS: What is the central question of this study? Does improved metabolic health and insulin sensitivity following a weight-loss and fitness intervention in sedentary, obesewomen alter exercise-associated fuel metabolism and incomplete mitochondrial fatty acid oxidation (FAO), as tracked by blood acylcarnitine patterns? What is the main finding and its importance? Despite improved fitness and blood sugar control, indices of incomplete mitochondrial FAO increased in a similar manner in response to a fixed load acute exercise bout; this indicates that intramitochondrial muscle FAO is inherently inefficient and is tethered directly to ATP turnover. With insulin resistance or type 2 diabetes mellitus, mismatches between mitochondrial fatty acid fuel delivery and oxidative phosphorylation/tricarboxylic acid cycle activity may contribute to inordinate accumulation of short- or medium-chain acylcarnitine fatty acid derivatives [markers of incomplete long-chain fatty acid oxidation (FAO)]. We reasoned that incomplete FAO in muscle would be ameliorated concurrent with improved insulin sensitivity and fitness following a ∼14 week training and weight-loss intervention in obese, sedentary, insulin-resistant women. Contrary to this hypothesis, overnight-fasted and exercise-induced plasma C4-C14 acylcarnitines did not differ between pre- and postintervention phases. These metabolites all increased robustly with exercise (∼45% of pre-intervention peak oxygen consumption) and decreased during a 20 min cool-down. This supports the idea that, regardless of insulin sensitivity and fitness, intramitochondrial muscle β-oxidation and attendant incomplete FAO are closely tethered to absolute ATP turnover rate. Acute exercise also led to branched-chain amino acid acylcarnitine derivative patterns suggestive of rapid and transient diminution of branched-chain amino acid flux through the mitochondrial branched-chain ketoacid dehydrogenase complex. We confirmed our prior novel observation that a weight-loss/fitness intervention alters plasma xenometabolites [i.e. cis-3,4-methylene-heptanoylcarnitine and γ-butyrobetaine (a co-metabolite possibly derived in part from gut bacteria)], suggesting that host metabolic health regulated gut microbe metabolism. Finally, we considered whether acylcarnitine metabolites signal to muscle-innervating afferents; palmitoylcarnitine at concentrations as low as 1-10 μm activated a subset (∼2.5-5%) of these neurons ex vivo. This supports the hypothesis that in addition to tracking exercise-associated shifts in fuel metabolism, muscle acylcarnitines act as signals of exertion to short-loop somatosensory-motor circuits or to the brain.
Authors: Brian D Piccolo; Kevin B Comerford; Sidika E Karakas; Trina A Knotts; Oliver Fiehn; Sean H Adams Journal: J Nutr Date: 2015-02-04 Impact factor: 4.798
Authors: Barbara Ukropcova; Michele McNeil; Olga Sereda; Lilian de Jonge; Hui Xie; George A Bray; Steven R Smith Journal: J Clin Invest Date: 2005-07 Impact factor: 14.808
Authors: Colin S McCoin; Trina A Knotts; Kikumi D Ono-Moore; Pieter J Oort; Sean H Adams Journal: Am J Physiol Endocrinol Metab Date: 2015-04-07 Impact factor: 4.310
Authors: Anneke M J van Hees; Anneke Jans; Gabby B Hul; Helen M Roche; Wim H M Saris; Ellen E Blaak Journal: Obesity (Silver Spring) Date: 2011-02-17 Impact factor: 5.002
Authors: Sean H Adams; Charles L Hoppel; Kerry H Lok; Ling Zhao; Scott W Wong; Paul E Minkler; Daniel H Hwang; John W Newman; W Timothy Garvey Journal: J Nutr Date: 2009-04-15 Impact factor: 4.798
Authors: René Rodríguez-Gutiérrez; Fernando J Lavalle-González; Laura E Martínez-Garza; Erick Landeros-Olvera; Juan C López-Alvarenga; Maria R Torres-Sepúlveda; Jose G González-González; Leonardo G Mancillas-Adame; Bertha Salazar-Gonzalez; Jesus Z Villarreal-Pérez Journal: J Int Soc Sports Nutr Date: 2012-05-10 Impact factor: 5.150
Authors: Jie Zhang; Sudeepa Bhattacharyya; Robert C Hickner; Alan R Light; Christopher J Lambert; Bruce K Gale; Oliver Fiehn; Sean H Adams Journal: Am J Physiol Endocrinol Metab Date: 2018-11-06 Impact factor: 4.310
Authors: Sudeepa Bhattacharyya; Mohamed Ali; William H Smith; Paul E Minkler; Maria S Stoll; Charles L Hoppel; Sean H Adams Journal: Am J Physiol Endocrinol Metab Date: 2017-08-22 Impact factor: 4.310
Authors: Sree V Chintapalli; Srinivas Jayanthi; Prema L Mallipeddi; Ravikumar Gundampati; Thallapuranam Krishnaswamy Suresh Kumar; Damian B van Rossum; Andriy Anishkin; Sean H Adams Journal: J Biol Chem Date: 2016-10-07 Impact factor: 5.157
Authors: Dmitry Grapov; Oliver Fiehn; Caitlin Campbell; Carol J Chandler; Dustin J Burnett; Elaine C Souza; Gretchen A Casazza; Nancy L Keim; John W Newman; Gary R Hunter; Jose R Fernandez; W Timothy Garvey; Charles L Hoppel; Mary-Ellen Harper; Sean H Adams Journal: Am J Physiol Endocrinol Metab Date: 2019-09-17 Impact factor: 4.310
Authors: Matthew Nayor; Ravi V Shah; Patricia E Miller; Jasmine B Blodgett; Melissa Tanguay; Alexander R Pico; Venkatesh L Murthy; Rajeev Malhotra; Nicholas E Houstis; Amy Deik; Kerry A Pierce; Kevin Bullock; Lucas Dailey; Raghava S Velagaleti; Stephanie A Moore; Jennifer E Ho; Aaron L Baggish; Clary B Clish; Martin G Larson; Ramachandran S Vasan; Gregory D Lewis Journal: Circulation Date: 2020-09-15 Impact factor: 29.690
Authors: Eline H van Roekel; Martijn J L Bours; Linda van Delden; Stéphanie O Breukink; Michèl Aquarius; Eric T P Keulen; Audrey Gicquiau; Vivian Viallon; Sabina Rinaldi; Paolo Vineis; Ilja C W Arts; Marc J Gunter; Michael F Leitzmann; Augustin Scalbert; Matty P Weijenberg Journal: Sci Rep Date: 2021-07-02 Impact factor: 4.379